Your browser doesn't support javascript.
loading
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study.
Garcia-Manero, Guillermo; Griffiths, Elizabeth A; Steensma, David P; Roboz, Gail J; Wells, Richard; McCloskey, James; Odenike, Olatoyosi; DeZern, Amy E; Yee, Karen; Busque, Lambert; O'Connell, Casey; Michaelis, Laura C; Brandwein, Joseph; Kantarjian, Hagop; Oganesian, Aram; Azab, Mohammad; Savona, Michael R.
Afiliação
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Steensma DP; Dana-Farber Cancer Institute, Boston, MA.
  • Roboz GJ; Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY.
  • Wells R; Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • McCloskey J; Hackensack University Medical Center, Hackensack, NJ.
  • Odenike O; The University of Chicago Pritzker School of Medicine, Chicago, IL.
  • DeZern AE; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD.
  • Yee K; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Busque L; Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
  • O'Connell C; USC Norris Comprehensive Cancer Center, Los Angeles, CA.
  • Michaelis LC; Medical College of Wisconsin, Milwaukee, WI.
  • Brandwein J; University of Alberta Hospital, Edmonton, AB, Canada.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Oganesian A; Astex Pharmaceuticals, Inc., Pleasanton, CA; and.
  • Azab M; Astex Pharmaceuticals, Inc., Pleasanton, CA; and.
  • Savona MR; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
Blood ; 136(6): 674-683, 2020 08 06.
Article em En | MEDLINE | ID: mdl-32285126
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged80 Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged80 Idioma: En Ano de publicação: 2020 Tipo de documento: Article